Bibert Stéphanie, Roy Sophie, Schaer Danièle, Horisberger Jean-Daniel, Geering Käthi
Department of Pharmacology and Toxicology, University of Lausanne, 27 Rue du Bugnon, 1005 Lausanne, Switzerland.
Department of Pharmacology and Toxicology, University of Lausanne, 27 Rue du Bugnon, 1005 Lausanne, Switzerland.
J Biol Chem. 2008 Jan 4;283(1):476-486. doi: 10.1074/jbc.M705830200. Epub 2007 Nov 8.
Phospholemman (FXYD1), mainly expressed in heart and skeletal muscle, is a member of the FXYD protein family, which has been shown to decrease the apparent K(+) and Na(+) affinity of Na,K-ATPase ( Crambert, G., Fuzesi, M., Garty, H., Karlish, S., and Geering, K. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 11476-11481 ). In this study, we use the Xenopus oocyte expression system to study the role of phospholemman phosphorylation by protein kinases A and C in the modulation of different Na,K-ATPase isozymes present in the heart. Phosphorylation of phospholemman by protein kinase A has no effect on the maximal transport activity or on the apparent K(+) affinity of Na,K-ATPase alpha1/beta1 and alpha2/beta1 isozymes but increases their apparent Na(+) affinity, dependent on phospholemman phosphorylation at Ser(68). Phosphorylation of phospholemman by protein kinase C affects neither the maximal transport activity of alpha1/beta1 isozymes nor the K(+) affinity of alpha1/beta1 and alpha2/beta1 isozymes. However, protein kinase C phosphorylation of phospholemman increases the maximal Na,K-pump current of alpha2/beta1 isozymes by an increase in their turnover number. Thus, our results indicate that protein kinase A phosphorylation of phospholemman has similar functional effects on Na,K-ATPase alpha1/beta and alpha2/beta isozymes and increases their apparent Na(+) affinity, whereas protein kinase C phosphorylation of phospholemman modulates the transport activity of Na,K-ATPase alpha2/beta but not of alpha1/beta isozymes. The complex and distinct regulation of Na,K-ATPase isozymes by phosphorylation of phospholemman may be important for the efficient control of heart contractility and excitability.
磷膜蛋白(FXYD1)主要表达于心脏和骨骼肌,是FXYD蛋白家族的成员,已证明它可降低钠钾ATP酶对钾离子和钠离子的表观亲和力(克兰伯特,G.,富泽西,M.,加蒂,H.,卡利什,S.,和吉林,K.(2002年)《美国国家科学院院刊》99,11476 - 11481)。在本研究中,我们利用非洲爪蟾卵母细胞表达系统来研究蛋白激酶A和蛋白激酶C对磷膜蛋白的磷酸化作用在调节心脏中不同钠钾ATP酶同工型方面的作用。蛋白激酶A对磷膜蛋白的磷酸化作用对钠钾ATP酶α1/β1和α2/β1同工型的最大转运活性或对钾离子的表观亲和力没有影响,但会增加它们对钠离子的表观亲和力,这取决于磷膜蛋白在丝氨酸68处的磷酸化。蛋白激酶C对磷膜蛋白的磷酸化作用既不影响α1/β1同工型的最大转运活性,也不影响α1/β1和α2/β1同工型对钾离子的亲和力。然而,蛋白激酶C对磷膜蛋白的磷酸化作用通过增加α2/β1同工型的周转数来增加其最大钠钾泵电流。因此,我们的结果表明,蛋白激酶A对磷膜蛋白的磷酸化作用对钠钾ATP酶α1/β和α2/β同工型具有相似的功能效应,并增加它们对钠离子的表观亲和力,而蛋白激酶C对磷膜蛋白的磷酸化作用调节钠钾ATP酶α2/β的转运活性,但不调节α1/β同工型的转运活性。磷膜蛋白磷酸化对钠钾ATP酶同工型的复杂且独特的调节可能对有效控制心脏收缩性和兴奋性很重要。